Is Essential Tremor Disrupting Your Ability to Perform Daily Activities?
Jazz Pharmaceuticals’ EveresT Study is a research study testing the safety and effectiveness of an investigational medication that may help decrease tremor severity in for people diagnosed with essential tremor (ET).
The study will last about 21 weeks, which includes a 1 to 7 week screening period, a 12-week treatment period, and a 2-week follow-up period. These three periods will involve approximately 8 visits to the study site and 8 phone calls from the study team, depending on your country regulations.
You may be able to participate if you are:
- 18 to 80 years of age
- Have ET and experience tremors in your hands or arms
- Have difficulty performing daily activities such as eating, drinking, dressing, or writing
There are other requirements for taking part in the study. The study team can discuss these requirements with you.
If you qualify and choose to enroll in the study, all study-related visits, tests, and investigational medication will be provided at no cost to you. In addition, reimbursement for time and travel may be provided.
Consider joining the EveresT Study and help us learn more about possible treatment options for patients with ET.